{
  "url": "https://www.law.cornell.edu/regulations/new-york/21-NYCRR-4255.2",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 21 ยง 4255.2 - Capital assistance program",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 21 ยง 4255.2 - Capital assistance program\n\nState Regulations\n(a) Definitions. For the purposes of this section, the terms below shall have\nthe following meaning: (1)\n\nLife sciences\nshall mean advanced and applied sciences that\nexpand the understanding of human physiology and have the potential to lead to\nmedical advances or therapeutic applications including, but not limited to, academic medical centers, agricultural biotechnology, biogenerics, bioinformatics, biomedical engineering, biopharmaceuticals, biotechnology, chemical synthesis, chemistry technology, diagnostics, genomics, image\nanalysis, marine biology, marine technology, medical devices, nanotechnology, natural product pharmaceuticals, proteomics, regenerative medicine, RNA\ninterference, stem cell research, clinical trials, including, but not limited\nto, neurological clinical trials and veterinary science. (2)\n\nLife sciences entity\nshall mean a business corporation, partnership, firm, unincorporated\nassociation, or any other entity engaged in life sciences research, development, manufacturing or commercialization, or collaborating with entities\nengaged in life sciences research, development, manufacturing or\ncommercialization. (3)\n\nCorporation\nshall mean the New York State Urban Development\n\nCorporation doing business as Empire State Development. (4)\n\nLife sciences economic\ndevelopment benefits\nmeans the creation, expansion, enhancement or\nacceleration of life sciences programs throughout the State that leads to: (i) the commercialization of life sciences in\n\nNew York State; (ii)\nthe creation\nor retention of jobs in the life sciences industry employing full time\npermanent employees; (iii)\nthe\npromotion of the life science ecosystem within a region of the State; (iv)\nnew patents in life science; (v) additional commercial laboratory space; or\n(vi)\nadditional venture capital\nmoney for Life Sciences Entities in New York State. (5)\n\nEvaluation criteria\nshall mean the criteria set forth in subdivision (d) of this section to be\napplied by the corporation in evaluating applications for Capital Assistance\n\nProgram funding. (6)\n\nFull\ntime permanent employee\nshall mean: (i) a full-time, permanent, employee on a\nlife sciences entity's payroll, who has worked at the project location for a\nminimum of 35 hours per week for not less than 4 consecutive weeks and who is\nentitled to receive the usual and customary fringe benefits extended by the\nentity to other employees with comparable rank and duties; or\n(ii)\ntwo part-time, permanent, private-sector\nemployees on the life sciences entity's payroll, who have worked at the project\nlocation for a combined minimum of 35 hours per week for not less than 4\nconsecutive weeks and who are entitled to receive the usual and customary\nfringe benefits extended by the entity to other employees with comparable rank\nand duties. (b) Available capital\nassistance. The Capital Assistance Program makes available financial\nassistance in the form of grants or loans (secured or unsecured), or a\ncombination of such assistance, or contracts for services in the corporation's\ndiscretion, for use by life sciences entities for eligible uses as set forth in\nsubdivision (e) of this section. (c) Application process. (1)\n\nApplications from life sciences entities\nwill be accepted on a rolling basis throughout the year. Life sciences entities\nrequesting capital assistance shall provide the following information about the\nproject and the applicant, as applicable, in a form provided by, or otherwise\nacceptable to, the corporation including, without limitation, the following: (i) a description of the project or activity, including information indicating how the proposed project or activity will\ncreate, expand, enhance or accelerate the commercial life science industry\nthrough programs, research, job creation and retention within New York State\nand will result in the other life sciences economic development benefits as\ndefined in paragraph (a)(4) of this section; (ii)\nthe number and amount of other funding, including Federal, that the applicant has applied for, is eligible for or has\nreceived for the same initiative; (iii)\nthe number of jobs in the life sciences\nindustry employing full time permanent employees to be created or retained as a\nresult of the proposed project or activity, the titles or classifications of\nsuch jobs and the average annual salaries associated with each; (iv)\ninformation about the applicant, including but not limited to, its history, ownership, size, primary products\noffered or services rendered, major customers, its market and marketing\nstrategy; (v) information about the\nproposed project financing including, but not limited to, total project cost, total program assistance requested, a budget breakdown of the sources and\nproposed uses of all funding, a description of the need for the requested\nprogram funding and justification for the amount requested; (vi)\na description of how the project will be\nimplemented, including a project schedule, and the current status of the\nproject; (vii)\nanticipated project\nresults; and\n(viii)\ninformation\nwith respect to the site of the project and the impact, if any, on the\nenvironment and any landmark or historic properties. (2)\n\nDepending on the nature of the project or\nactivity (such as acquisition of machinery and equipment; acquisition, construction or renovation of property, etc.) and the type of assistance\nrequested, life science entities may be required to provide other information\nabout the project, including some or all of the following, as may be\nappropriate: (i) a complete set of financial\nstatements for at least the three preceding fiscal years, operating\npro\nformas\ngoing forward three years, and current financial statements for\nany proposed guarantors; (ii)\na\nlist of proposed collateral, with any available appraisals; (iii)\nresumes of principal officers and a\nlist of owners, shareholders, or partners; (iv)\na copy of any related real estate\npurchase option or contract for sale; (v) a legal description and survey of the\nproperty; (vi)\na\nconstruction-to-occupancy schedule; and\n(vii)\ncopies of any preliminary architectural\ndrawings, scope of work, cost estimates and schematics. (3)\n\nApplications may include a request for\nfunding for single or multiple life sciences projects or activities. (4)\n\nUpon receipt of the application, the\ncorporation shall review the application for eligibility, completeness, and\nconformance with the applicable requirements of these guidelines. Applications\nshall be processed in full compliance with the applicable provisions of section\n16-aa of the New York State Urban Development Corporation Act. (5)\n\nThe corporation may issue a request for\nproposals for contracts for services in lieu of an application where it deems\nit appropriate. Such request for proposals will set forth eligibility\nguidelines which may differ from those contained herein. (d) Evaluation criteria. The corporation shall evaluate applications for capital\nassistance in accordance with the following criteria as applicable: (1)\nthe financial condition of the entity\nundertaking the project, including its profitability or potential to generate\nprofits; liquidity; ability to service debt and its leverage ratio; (2)\nmanagement experience, ability and\nrelevant knowledge and the relevant entity's general ability to carry out the\nproject; (3)\nsatisfactory credit\nreferences; (4)\nthe absence of\n\nState or local tax judgments; provided however, in the case of a tax certiorari\nproceeding a life sciences entity would not be considered in arrears until a\nfinal decision is made with respect to such proceeding; (5)\nwhether the applicant clearly\ndemonstrates how the proposal will result in life sciences economic development\nbenefits and the likelihood that the project will result in life sciences\neconomic development benefits to the State; (6)\nthe availability of other sources of\nfunding, including offers of assistance from locations outside of the State, including the Federal government, and the amount of private financing leveraged\nby program funds; and\n(7)\nthe\ncorporation may consider the terms of any economic development assistance\navailable as an incentive for the location of the proposed project outside the\n\nState. (e) Eligible\nuses. Capital assistance program funds may be used for: (1)\nnew construction, renovation or leasehold\nimprovements; (2)\nthe acquisition\nor leasing of land, buildings, machinery and equipment; (3)\nworking capital, including, without\nlimitation, workforce development; (4)\nfeasibility or planning studies related\nto the development of commercial life sciences in the State; and\n(5)\ncontracts for services to support New\n\nYork life sciences' ecosystem. (f) Ineligible uses. Institutions that are exclusively health care providers\nand/or requests for the purchase of equipment associated with standard\nhealthcare delivery are not eligible for capital assistance program\nfunding. (g) Reporting\nrequirements. Applicants shall submit an annual report satisfactory to the\ncorporation on the operation and accomplishments of the project including, without limitation, a description of the activities undertaken, the economic\nimpact of the project, the number and amount of other sources of funding for\nthe project including Federal funds, jobs employing full time permanent\nemployees created and retained, and the average salary of such\njobs. Notes\nN.Y. Comp. Codes\nR. & Regs. Tit. 21\nยง\n4255.2\n\nAmended\n\nNew\n\nYork State Register May 22, 2019/Volume XLI, Issue 21, eff. 5/2/2019\n\nAmended\n\nNew\n\nYork State Register November 20, 2019/Volume XLI, Issue 47, eff. 11/20/2019\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 43600
}